Myasthenia Gravis Resource Access Analysis Across 12 Latin American Countries

12 Latin American and Caribbean countries were surveyed on diagnostic and therapeutic resources for myasthenia gravis. The study, authored by Valeria L. Salutto and published in 2026, assesses availability, costs, and access barriers within public healthcare systems. It documents inequalities in resource coverage and out-of-pocket expenses relative to local minimum wages.

Use Cases

• Analyze correlations between country-level data on neurologist availability and reported diagnostic access barriers.
• Model the financial burden of myasthenia gravis treatment using data on out-of-pocket costs relative to minimum wages.
• Compare the availability of specific diagnostic tests and therapies across the 12 surveyed countries.
• Identify regional patterns in public healthcare system coverage for novel myasthenia gravis treatments.

Strengths

• Data covers 12 distinct countries in Latin America and the Caribbean.
• Includes concrete financial metrics, such as out-of-pocket costs compared to minimum wage.

Limitations

• The dataset is a 672.1 KB document, indicating a limited scope and likely small sample size for quantitative analysis.
• Data is presented in a DOCX report format, not structured for direct computational analysis.
• The exploratory descriptive methodology may limit generalizability and statistical power.

Provenance

Source

figshare, authored by Valeria L. Salutto.

Collection Method

Exploratory descriptive study conducted via assessment across 12 countries.

Time Range

null

Freshness

Last updated in April 2026.

Geography

Latin America and the Caribbean, specifically 12 countries within the region.